-+ 0.00%
-+ 0.00%
-+ 0.00%

*Vyome Plans to Continue Engagement With FDA Through Type C Meeting to Further Advance Clinical Development Program >HIND

Dow Jones·08/25/2026 12:09:00

Please log in to view news